PJP

Invesco Dynamic Pharmaceuticals ETF
*Unless otherwise stated, data provided by FactSet.

PJP Fund Description

PJP tracks an index of US pharmaceutical companies selected and weighted based on various factors using a quantitative methodology.

PJP Factset Analytics Insight

PJP uses a quant-driven methodology to select and weight pharmaceutical companies based on fundamental and risk factors. Specifically, the fund holds about 30 US stocks that are evaluated based on five factors: price momentum, earnings momentum, quality, management action, and value. Although some of the major names are represented in the portfolio, PJP’s multi-factor selection process and tier-weighting scheme tilts the fund toward mid and small-caps resulting in a low overall weighted average market cap. It therefore reduces concentrations in mega-caps and evenly weights the group of companies across size. Still, its small portfolio takes concentrated stakes in some leading names. The fund and the index are rebalanced and reconstituted quarterly in February, May, August and November.

PJP MSCI ESG Analytics Insight

Invesco Dynamic Pharmaceuticals ETF has an MSCI ESG Fund Rating of A based on a score of 6.18 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Invesco Dynamic Pharmaceuticals ETF ranks in the 36th percentile within its peer group and in the 58th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

PERFORMANCE [as of 01/18/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
PJP 2.70% 1.70% -2.66% 4.48% 7.65% 7.68% 12.34%
PJP (NAV) -1.79% 1.47% -4.16% 2.77% 6.16% 7.61% 12.02%
Dynamic Pharmaceutical Intellidex Index -1.75% 1.53% -4.14% 3.26% 6.73% 8.20% 12.65%
Thomson Reuters US Pharmaceuticals -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

PJP Summary Data

Invesco
06/23/05
Open-Ended Fund
0.58%
$351.69M
$1.45M
0.11%

PJP Portfolio Data

$106.34B
38.33
3.80
0.83%
N/A
27

PJP Index Data

Tiered
Multi-Factor
Thomson Reuters US Pharmaceuticals

PJP Portfolio Management

0.58%
-0.69%
-0.08%
-0.92%

PJP Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

PJP Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

PJP Factset Analytics Block Liquidity

As of 01/19/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PJP. PJP is rated a 5 out of 5.

PJP Tradability

18,278
$1.45M
13,965
$1.12M
0.11%
$0.09
0.00%
0.19% / -0.24%
None
97.00%
50,000
0.28
0.01%
0.73%
32
$77.66
5

PJP Top 10 Holdings[View All]

AbbVie, Inc. 6.68%
Amgen Inc. 6.52%
Pfizer Inc. 5.97%
55.33%

PJP Countries


PJP
Segment Benchmark
100.00%
100.00%

PJP Regions


PJP
Segment Benchmark
100.00%
100.00%

PJP Economic Development


PJP
Segment Benchmark
100.00%
100.00%

PJP Performance Statistics

0.55
0.81
0.79
0.64
0.62%
Thomson Reuters US Pharmaceuticals

PJP MSCI ESG Ratings

6.18 / 10
57.83
35.72
--
--
29.17

PJP Benchmark Comparison Holdings

27
68
17
38.44%

PJP Benchmark Comparison Summary


PJP
Segment Benchmark
27
68
$106.34B
$234.91B
38.33
34.30
3.80
5.80
1.47%
2.63%
High
High

PJP Benchmark Comparison Market Cap Size


PJP
Segment Benchmark
54.79%
96.40%
15.68%
1.89%
29.53%
1.35%
0.00%
0.32%